Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signalingYi Zheng, Pei‐Hui Wang|Signal Transduction and Targeted Therapy|2020Cited by 301
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granulesYi Zheng, Pei‐Hui Wang|Signal Transduction and Targeted Therapy|2022Cited by 175
SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathwaysJian Deng, Pei‐Hui Wang, Lulu Han et al.|Journal of Medical Virology|2023Cited by 37
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) Protein Inhibits Type I and III Interferon Production by Targeting RIG-I/MDA-5 SignalingYi Zheng, Pei‐Hui Wang|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 31
SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathwaysJian Deng, Pei‐Hui Wang, Shengnan Zheng et al.|Journal of Medical Virology|2023Cited by 24